GPRC5D
GPRC5D (G Protein-Coupled Receptor Class C Group 5 Member D) is a protein that in humans is encoded by the GPRC5D gene. It is a member of the G protein-coupled receptor family, which is a large family of cell surface receptors that respond to various external stimuli and play a crucial role in many physiological processes.
Function[edit]
GPRC5D is primarily expressed in the placenta and to a lesser extent in the lung and pancreas. It is also found in multiple myeloma cells. The exact function of GPRC5D is not fully understood, but it is believed to play a role in the regulation of cell growth and differentiation.
Clinical significance[edit]
GPRC5D is a potential target for the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. Studies have shown that GPRC5D is highly expressed in multiple myeloma cells, and targeting this receptor with monoclonal antibodies has shown promise in preclinical studies.
Research[edit]
Research into the function and potential therapeutic applications of GPRC5D is ongoing. Understanding the role of this receptor in normal physiology and disease could lead to the development of new treatments for multiple myeloma and potentially other diseases.
See also[edit]
References[edit]
| Human Proteins | ||||||||
|---|---|---|---|---|---|---|---|---|
This human proteins-related article is a stub. You can help WikiMD by expanding it.
|
| Genetics and Genomics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Oncology | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This oncology-related article is a stub.
|
GPRC5D[edit]
-
GPRC5D complexed with Talquetamab Fab (PDB: 9IMA)
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian